The market size of Deep Brain Stimulation (DBS) Devices Market Growth was estimated to be USD 1.14 billion in 2022. It is projected to reach USD 2.23 billion by 2030, with a compound annual growth rate (CAGR) of 9.9% during the forecast period from 2023 to 2030.
Deep Brain Stimulation (DBS) Devices have emerged as a significant player in the healthcare industry, offering promising solutions for various neurological disorders. The market's steady growth can be attributed to the rising prevalence of conditions such as Parkinson's disease, essential tremors, and dystonia, among others.
DBS devices utilize electrical stimulation to target specific areas of the brain, effectively managing symptoms and improving the quality of life for patients. This non-invasive treatment option has gained traction due to its ability to alleviate symptoms that are often unresponsive to medication or other therapies.
Furthermore, technological advancements and ongoing research in the field have led to the development of more sophisticated DBS devices, enhancing their efficacy and expanding their applications. The increasing adoption of these devices by healthcare professionals and the growing awareness among patients about the benefits of DBS therapy are driving the market's growth.
Geographically, North America holds a significant share in the DBS devices market, primarily due to the region's well-established healthcare infrastructure and the presence of key market players. However, the Asia-Pacific region is expected to witness substantial growth during the forecast period, driven by the rising geriatric population and increasing healthcare expenditure in countries like China and India.
In conclusion, the Deep Brain Stimulation (DBS) Devices market is poised for substantial growth in the coming years. With the increasing prevalence of neurological disorders and advancements in technology, DBS devices offer a promising solution for patients seeking effective symptom management. As the market continues to expand, it presents lucrative opportunities for both existing and new players in the healthcare industry.
.
Get Sample Report @ https://www.snsinsider.com/sample-request/3335
Market Segmentation Analysis
By Product
- Single Channel
- Dual Channel
By Application
- Pain Management
- Epilepsy
- Essential Tremor
- Obsessive-Compulsive Disorder (OCD)
- Depression
- Dystonia
- Parkinson’s Disease
- Others
By End Use
- Hospitals
- Neurology Clinics
- Ambulatory Surgical Centres
- Research Centres
Key Players
The major key players are, Nevro Corporation, Abbott Laboratories, Neuronetics Inc., Aleva Neurotherapeutics SA, Beijing PINS Medical Co., Ltd., LivaNova PLC and others.
Table of Contents
1.Introduction
2.Research Methodology
3.Market Dynamics
4.Impact Analysis
4.1COVID-19 Impact Analysis
4.2.Impact of Ukraine- Russia war
4.3.Impact of Ongoing Recession on Major Economies
5.Value Chain Analysis
6.Porter’s 5 Forces Model
7.PEST Analysis
8.Deep Brain Stimulation (DBS) Devices Market Segmentation, By Product
9.Deep Brain Stimulation (DBS) Devices Market Segmentation, By Application
10. Deep Brain Stimulation (DBS) Devices Market, By End Use
11.Regional Analysis
12 Company profile
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Akash Anand – Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: https://www.snsinsider.com